UCB - Cost Of Sales

Stock Price
252.30
Daily Change
3.90 1.57%
Monthly
-0.39%
Yearly
38.97%
Q1 Forecast
269.39

UCB reported EUR901M in Cost of Sales for its fiscal semester ending in December of 2024.





Cost Of Sales Change Date
Alcon AG USD 1.16B 52M Sep/2025
Almirall EUR 191.5M 2.29M Dec/2025
Amarin USD 16.89M 18.51M Mar/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Orion EUR 186.6M 17.6M Dec/2025
Recordati EUR 199.91M 20.12M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 901M 50M Dec/2024
Unibail Rodamco EUR 537M 108.4M Jun/2025